Keyphrases
Poly(methyl methacrylate)
100%
Rifamycin
100%
Staphylococcal Biofilms
100%
Biofilm
58%
Rifampin
41%
Open Fracture
25%
Staphylococcus Aureus
16%
Bacterial Recovery
16%
Antibiotics
8%
Intracellular Bacteria
8%
Clinical Significance
8%
Effective Treatment
8%
Effective Strategies
8%
Antimicrobial Therapy
8%
Local Delivery
8%
Antimicrobial
8%
Sustained Release
8%
Vancomycin
8%
Infection Prevention
8%
Gentamicin Protection Assay
8%
Release Kinetics
8%
Infection Treatment
8%
Release Profile
8%
Local Antimicrobials
8%
S. Aureus Biofilm
8%
Biofilm Inhibition
8%
Staphylococcus Aureus Biofilm
8%
Osteoblast Viability
8%
Curing Time
8%
High-throughput Model
8%
Osteoarticular Infections
8%
Biofilm Eradication
8%
Antimicrobial Delivery
8%
Internalized Bacteria
8%
Pharmacology, Toxicology and Pharmaceutical Science
Poly(methyl Methacrylate)
100%
Rifamycin Derivative
100%
Rifampicin
62%
Staphylococcus Aureus
50%
Rifamycin
50%
Open Fracture
37%
Infection
25%
Antiinfective Agent
25%
Intracellular Bacterium
12%
Clinical Study
12%
Vancomycin
12%
Gentamicin
12%
Veterinary Science and Veterinary Medicine
Staphylococcus aureus
100%
Infectious Disease
50%
Staphylococcus
50%
Osteoblast
25%